Tsai D E, Stadtmauer E A, Canaday D J, Vaughn D J
Hematology-Oncology Division, University of Pennsylvania Medical Center, Philadelphia 19104, USA.
Med Oncol. 1998 Dec;15(4):279-81. doi: 10.1007/BF02787213.
The optimal treatment for posttransplant lymphoproliferative disorder which has progressed despite a reduction in immunosuppression has not been defined. We report on two patients with stage I posttransplant lymphoproliferative disorder who developed progressive disease despite a reduction in the level of immunosuppression. Both patients were treated with combined short course CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) chemotherapy followed by involved-field radiation therapy. In both patients, a rapid response was obtained followed by complete remission. Combined modality therapy can be utilized successfully in progressive limited stage posttransplant lymphoproliferative disorder.
尽管免疫抑制水平降低,但仍进展的移植后淋巴细胞增生性疾病的最佳治疗方法尚未明确。我们报告了两名I期移植后淋巴细胞增生性疾病患者,尽管免疫抑制水平降低,但仍出现疾病进展。两名患者均接受了短疗程CHOP(环磷酰胺、阿霉素、长春新碱和泼尼松)联合化疗,随后进行受累野放射治疗。两名患者均迅速出现反应,随后完全缓解。联合治疗模式可成功用于进展性局限期移植后淋巴细胞增生性疾病。